Features Associated With Quality of Life Impairment in Hidradenitis Suppurativa Patients

Frontiers in Medicine

Björn Fritz¹  Sylke Schneider-Burrus²  Robert Sabat³  Katrin Witte⁴  Kerstin Wolk⁵  Athanasia Tsaousi⁶  Johannes Huss-Marp⁷  Sebastian Barbus⁷ 

[1] AbbVie Deutschland GmbH & Co. KG, Wiesbaden, Germany;Interdisciplinary Group of Molecular Immunopathology, Dermatology/Medical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany;Center for Dermatosurgery, Havelklinik, Berlin, Germany;Interdisciplinary Group of Molecular Immunopathology, Dermatology/Medical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany;Psoriasis Research and Treatment Center, Charité - Universitätsmedizin Berlin, Berlin, Germany;Interdisciplinary Group of Molecular Immunopathology, Dermatology/Medical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany;Psoriasis Research and Treatment Center, Charité - Universitätsmedizin Berlin, Berlin, Germany;Berlin Institute of Health (BIH) Center for Regenerative Therapies, Charité-Universitätsmedizin Berlin, Berlin, Germany;Interdisciplinary Group of Molecular Immunopathology, Dermatology/Medical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany;Psoriasis Research and Treatment Center, Charité - Universitätsmedizin Berlin, Berlin, Germany;Berlin Institute of Health (BIH) Center for Regenerative Therapies, Charité-Universitätsmedizin Berlin, Berlin, Germany;Department of Dermatology, Venereology, and Allergology, Charité – Universitätsmedizin Berlin, Berlin, Germany;Psoriasis Research and Treatment Center, Charité - Universitätsmedizin Berlin, Berlin, Germany;Sanofi-Aventis Deutschland GmbH, Frankfurt, Germany;

关键词: skin disease;    quality of life;    dermatology life quality index;    obesity;    spondyloarthritis;    metabolic syndrome;    family history;   

DOI  :  10.3389/fmed.2021.676241

来源: Frontiers

【 授权许可】

CC BY